Results 181 to 190 of about 1,034,952 (285)

CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. [PDF]

J Gynecol Oncol
Lim MC.
europepmc   +1 more source

Whole Abdominal Radiotherapy Is Tolerable and Effective in Children and Young Adults With Intra‐Abdominal Sarcoma: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Whole abdominal radiotherapy (WART) is utilized in children, adolescents, and young adults with intra‐abdominal sarcoma, but efficacy and toxicity are uncertain. Methods Sarcoma patients diagnosed at ≤39 years of age between 1998 and 2023 who received WART were identified from a national registry.
Rebecca J. Deyell, Hagit Peretz Soroka, Delaney Sharp, Caroline Ruus, Jeffrey N. Bone, Mai‐Kim Gervais, Audrey Roux, Xiaolan Feng, Natalie Logie, Nicolas Prudhomme, Caroline Holloway, Abha A. Gupta, Derek S. Tsang   +12 more
wiley   +1 more source

Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments. [PDF]

J Gastrointest Oncol
Elnahla A, Guerra-Londono CE.
europepmc   +1 more source

Treatment of Intermediate‐Risk Hepatoblastoma Using a Combined Cisplatin and Doxorubicin (PLADO) Regimen and Optimized Surgical Resection

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Complete resection of the primary tumor is critical for the survival of children with hepatoblastomas (HBs). This prospective clinical study aimed to clarify the outcome of a chemotherapy regimen comprising cisplatin and doxorubicin (PLADO) followed by definitive surgery conducted at the appropriate time in patients with ...
Tomoro Hishiki, Kohmei Ida, Kenichiro Watanabe, Makiko Mori, Junya Fujimura, Yuki Nogami, Tomoko Iehara, Ken Hoshino, Akiko Yokoi, Shohei Honda, Takuro Kazama, Masahiro Sekiguchi, Norihiko Kitagawa, Risa Matsumura, Motonari Nomura, Yohei Yamada, Ryo Hanaki, Hide Kaneda, Yuichi Takama, Takeshi Inoue, Yukichi Tanaka, Osamu Miyazaki, Hiroki Nagase, Tetsuya Takimoto, Kenichi Yoshimura, Eiso Hiyama   +25 more
wiley   +1 more source

Effectiveness of hyperthermic intraperitoneal chemotherapy during primary curative resection for colorectal carcinoma. [PDF]

Int J Colorectal Dis
Zhou H, Wang H, Yi S, Yu S.
europepmc   +1 more source

Colorectal Carcinoma in Childhood and Adolescence: Microsatellite Instability Correlates With a Favorable Prognosis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Colorectal cancer (CRC) accounts for 10% of cancer cases worldwide; however, pediatric CRC is extremely rare, with an annual incidence of one to two cases per million. Microsatellite instability (MSI) has been shown to play a relevant prognostic role in adult CRC. Corresponding data for pediatric CRC are lacking. This study examines
Hannah Wild, Alexandra Liebmann, Lucas Maennel, Linda Maschke, Andreas Block, Leo Kager, Udo Kontny, Abbas Agaimy, Michaela Kuhlen, Antje Redlich, Andreas Schmidt, Jörg Fuchs, Dominik T. Schneider, Ines B. Brecht, Michael Abele   +14 more
wiley   +1 more source

Modeling the drug transport in a single tumor nodule during intraperitoneal chemotherapy [PDF]

, 2015
Ceelen, Wim, Debbaut, Charlotte, Segers, Patrick, Steuperaert, Margo   +3 more
core   +1 more source

Hyperthermic intraperitoneal chemotherapy in colorectal cancer. [PDF]

BJS Open
Fisher OM, Brown C, Esquivel J, Larsen SG, Liauw W, Alzahrani NA, Morris DL, Kepenekian V, Sourrouille I, Dumont F, Tuech JJ, Ceribelli C, Doussot B, Sgarbura O, Alhosni M, Quenet F, Glehen O, Cashin PH, Peritoneal Surface Oncology Group International (PSOGI), Nordic Peritoneal Oncology Group (NPOG), American Society for Peritoneal Surface Malignancy (ASPSM) and BIG-RENAPE Groups .   +20 more
europepmc   +2 more sources

Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Can We Do Better? [PDF]

J Surg Oncol
Alberto V ME, Zuluaga D, Winter A, Pratschke J, Rau B, Gül S.   +5 more
europepmc   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

Small, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai, Dhwani Rana, Mitali Patel, Neha Bajwa, Rajendra Prasad, Lalitkumar K. Vora   +5 more
wiley   +1 more source